South Korea · Delayed Price · Currency is KRW Ildong Pharmaceutical Statistics
Total Valuation
KRX:249420 has a market cap or net worth of KRW 838.11 billion. The enterprise value is 916.56 billion.
| Market Cap | 838.11B |
| Enterprise Value | 916.56B |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
KRX:249420 has 31.51 million shares outstanding. The number of shares has increased by 10.01% in one year.
| Current Share Class | 31.51M |
| Shares Outstanding | 31.51M |
| Shares Change (YoY) | +10.01% |
| Shares Change (QoQ) | +23.11% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 3.70% |
| Float | 20.60M |
Valuation Ratios
The trailing PE ratio is 28.40 and the forward PE ratio is 20.44.
| PE Ratio | 28.40 |
| Forward PE | 20.44 |
| PS Ratio | 1.48 |
| PB Ratio | 3.42 |
| P/TBV Ratio | 3.75 |
| P/FCF Ratio | 158.01 |
| P/OCF Ratio | 44.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.81, with an EV/FCF ratio of 172.80.
| EV / Earnings | 33.13 |
| EV / Sales | 1.62 |
| EV / EBITDA | 22.81 |
| EV / EBIT | 52.06 |
| EV / FCF | 172.80 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.59.
| Current Ratio | 0.99 |
| Quick Ratio | 0.51 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 3.62 |
| Debt / FCF | 27.23 |
| Interest Coverage | 1.42 |
Financial Efficiency
Return on equity (ROE) is 11.51% and return on invested capital (ROIC) is 3.95%.
| Return on Equity (ROE) | 11.51% |
| Return on Assets (ROA) | 1.86% |
| Return on Invested Capital (ROIC) | 3.95% |
| Return on Capital Employed (ROCE) | 4.98% |
| Weighted Average Cost of Capital (WACC) | 10.12% |
| Revenue Per Employee | 534.34M |
| Profits Per Employee | 26.07M |
| Employee Count | 1,061 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 3.69 |
Taxes
In the past 12 months, KRX:249420 has paid 8.06 billion in taxes.
| Income Tax | 8.06B |
| Effective Tax Rate | 25.37% |
Stock Price Statistics
The stock price has increased by +137.08% in the last 52 weeks. The beta is 1.19, so KRX:249420's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +137.08% |
| 50-Day Moving Average | 33,905.00 |
| 200-Day Moving Average | 27,861.95 |
| Relative Strength Index (RSI) | 33.56 |
| Average Volume (20 Days) | 170,309 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:249420 had revenue of KRW 566.93 billion and earned 27.66 billion in profits. Earnings per share was 936.77.
| Revenue | 566.93B |
| Gross Profit | 219.58B |
| Operating Income | 17.32B |
| Pretax Income | 31.75B |
| Net Income | 27.66B |
| EBITDA | 39.90B |
| EBIT | 17.32B |
| Earnings Per Share (EPS) | 936.77 |
Balance Sheet
The company has 64.96 billion in cash and 144.41 billion in debt, with a net cash position of -79.45 billion or -2,521.65 per share.
| Cash & Cash Equivalents | 64.96B |
| Total Debt | 144.41B |
| Net Cash | -79.45B |
| Net Cash Per Share | -2,521.65 |
| Equity (Book Value) | 245.41B |
| Book Value Per Share | 7,820.92 |
| Working Capital | -3.10B |
Cash Flow
In the last 12 months, operating cash flow was 18.95 billion and capital expenditures -13.65 billion, giving a free cash flow of 5.30 billion.
| Operating Cash Flow | 18.95B |
| Capital Expenditures | -13.65B |
| Depreciation & Amortization | 22.58B |
| Net Borrowing | -33.57B |
| Free Cash Flow | 5.30B |
| FCF Per Share | 168.34 |
Margins
Gross margin is 38.73%, with operating and profit margins of 3.06% and 4.88%.
| Gross Margin | 38.73% |
| Operating Margin | 3.06% |
| Pretax Margin | 5.60% |
| Profit Margin | 4.88% |
| EBITDA Margin | 7.04% |
| EBIT Margin | 3.06% |
| FCF Margin | 0.94% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | 200.00 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 0.22% |
| Buyback Yield | -10.01% |
| Shareholder Yield | -9.26% |
| Earnings Yield | 3.30% |
| FCF Yield | 0.63% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 5, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Mar 5, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |
Scores
KRX:249420 has an Altman Z-Score of 2.38 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.38 |
| Piotroski F-Score | 6 |